Aroyl pyrrolizine compounds, process for their preparation and pharmaceutical compositions containing them
申请人:BEECHAM GROUP PLC
公开号:EP0091181A2
公开(公告)日:1983-10-12
Compounds of formula (I)
wherein:
Ar is phenyl optionally substituted in the o-, m- or p-position by C1-4 alkyl, C1-4 alkoxy, halo, C1-4 alkylthio or trifluoromethyl, 2-pyrryl optionally N-substituted by C1-4 alkyl, 2-furyl or 2-thienyl either being optionally substituted in the 3-, 4-, or 5- position by C1-4 alkyl, chloro or bromo, 3-furyl, or 3-thienyl;
R, is hydrogen, C1-4 alkyl, fluoro, bromo or chloro; and
X is CH2 and either Y is CO, CHOH, CH(OCOR2) or C(OR3)OR4, and Z is CH3, or Y and Z together are C(OR5)=CH2 or C(OCOR5)=CH2, or X is CHOH, Y is CHOH or CO and Z is CH3, or X and Y together are CH=C(OR5) or CH=C(OCOR5) and Z is CH3, in which R2 is phenyl optionally subsituted in the o-, m- or p- position by C1-4 alkyl, C1-4 alkoxy or halo, or is C1-7 alkyl optionally substituted by phenyl or amino, R3 and R4 are C1-4 alkyl or together are C2-3 polymethylene, and R5 is C1-4 alkyl having anti-inflammatory and analgesic activity.
式(I)化合物
其中
Ar 是在邻位、间位或对位任选被 C1-4 烷基、C1-4 烷氧基、卤代、C1-4 烷硫基或三氟甲基取代的苯基,是任选被 C1-4 烷基、2-呋喃基或 2-噻吩基 N 取代的 2-吡喃基,是任选在 3-、4-或 5-位被 C1-4 烷基、氯代或溴代取代的 2-呋喃基或 3-噻吩基;
R 是氢、C1-4 烷基、氟、溴或氯;以及
X 为 CH2,Y 为 CO、CHOH、CH(OCOR2)或 C(OR3)OR4,Z 为 CH3,或 Y 和 Z 同为 C(OR5)=CH2 或 C(OCOR5)=CH2,或 X 为 CHOH,Y 为 CHOH 或 CO,Z 为 CH3,或 X 和 Y 同为 CH=C(OR5) 或 CH=C(OCOR5) ,Z 为 CH3,其中 R2 为在 o-、m-位或 p-位任选被 C1-4 烷基、C1-4 烷氧基或卤代取代的苯基,或任选被苯基或氨基取代的 C1-7 烷基,R3 和 R4 为 C1-4 烷基或合在一起为 C2-3 聚亚甲基,R5 为具有消炎和镇痛活性的 C1-4 烷基。